Hostname: page-component-857557d7f7-c8jtx Total loading time: 0 Render date: 2025-11-24T13:48:43.095Z Has data issue: false hasContentIssue false
  • English
  • Français

A yellow fever vaccine free from avian leucosis viruses

Published online by Cambridge University Press:  15 May 2009

C. C. Draper
C. C. Draper
Affiliation:
Wellcome Research Laboratories, Beckenham
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. The methods used for clearing a vaccine substrain of 17 D yellow fever virus of contaminant avian leucosis viruses are described.

2. Tests in animals and human subjects showed that the characteristics of the virus remained unchanged.

Information

Type
Research Article
Information
Journal of Hygiene , Volume 65 , Issue 4 , December 1967 , pp. 505 - 513
Copyright
Copyright © Cambridge University Press 1967

References

REFERENCES

Bodian, D. (1948). The virus, the nerve cell, and paralysis. A study of experimental poliomyelitis in the spinal cord. Bull. Johns Hopkins Hosp. 83, 1.Google ScholarPubMed
Feitel, M., Watson, E. H. & Cochran, K. W. (1960). Encephalitis after yellow fever vaccination. Pediatrics, Springfield 25, 956.CrossRefGoogle ScholarPubMed
Fox, J. P., Lennette, E. H., Manso, C. & Aguiar, J. R. S. (1942). Encephalitis in man following vaccination with 17 D yellow fever virus. Am. J. Hyg. 36, 117.Google Scholar
Fox, J. P. & Penna, H. A. (1943). Behaviour of 17 D yellow fever virus in rhesus monkeys. Am. J. Hyg. 38, 152.Google Scholar
Harris, R. J. C., Dougherty, R. M., Biggs, P. M., Payne, L. N., Goffe, A. P., Churchill, A. E. & Mortimer, R. (1966). Contaminant viruses in two live virus vaccines produced in chick cells. J. Hyg., Camb. 64, 1.CrossRefGoogle ScholarPubMed
Meers, P. D. (1959). Adaption of the 17 D yellow fever virus to mouse brain by serial passage. Trans. R. Soc. trop. Med. Hyg. 53, 445.CrossRefGoogle Scholar
Nathanson, N., Goldblatt, D., Thind, I. S., Davis, M. & Price, W. H. (1966 a). Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale. Am. J. Epidem. 82, 359.CrossRefGoogle Scholar
Nathanson, N., Davis, M., Thind, I. S., & Price, W. H. (1966 b). Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers. Am. J. Epidem. 84, 524.CrossRefGoogle ScholarPubMed
Permanent section of microbiological Standardization of the International Association of Microbiological Societies (1967). Proc. of the 13th Symposium, 1965. Neurovirulence of Viral Vaccines. Basel and New York: Karger.Google Scholar
Piraino, F., Krumbiegel, E. R. & Wisniewski, H. J. (1967). Serologic survey of man for avian leucosis virus infection. J. Immun. 98, 702.CrossRefGoogle Scholar
Rubin, H. (1960). A virus in chick embryo which induces resistance in vitro to infection with Rous sarcoma virus. Proc. natn. Acad. Sci. Wash. 46, 1105.CrossRefGoogle Scholar
Sencer, D. J. et al. (1966). Fatal virus encephalitis following 17D yellow fever vaccine inoculation. J. Am. med. Ass. 198, 671.Google Scholar
Smith, C. E. G., Turner, L. H. & Armitage, P. (1962). Yellow fever vaccination in Malaya by subcutaneous injection and multiple puncture. Neutralizing antibody responses in persons with and without pre-existing antibody to related viruses. Bull. Wld Hlth Org. 27, 717.Google ScholarPubMed
Smith, C. E. G., McMahon, D. A. & Turner, L. H. (1963). Yellow fever vaccination in Malaya by subcutaneous injection and multiple puncture. Haemagglutinin-inhibiting antibody responses in persons with and without pre-existing antibody. Bull. Wld Hlth Org. 29, 75.Google ScholarPubMed
Soper, F. L. & Smith, H. H. (1938). Vaccination with virus 17D in control of jungle yellow fever in Brazil. Acta Convent, tert. de trop. malar. Morbis, Amsterdam. 1, 295.Google Scholar
Stuart, G. (1956). Post vaccination reactions in Yellow Fever Vaccination. Monograph Series W.H.O. no. 30.Google Scholar
Theiler, M. (1951). The virus, in Yellow Fever. Ed. Strode, G. K.. New York: McGraw Hill.Google Scholar
Vogt, P. K. (1965). Avian tumor viruses. Adv. Virus Res. 11, 293.CrossRefGoogle ScholarPubMed
Webb, H. E. & Smith, C. E. G. (1966). Relation of immune response to development of central nervous system lesions in virus infections of man. Br. med. J. ii, 1179.CrossRefGoogle Scholar
W.H.O. (1959). Requirements for Yellow Fever Vaccine. Tech Rep. Ser. Wld Hlth Org., no. 179.Google Scholar
W.H.O. (1966 a). Requirements for measles vaccines. In 18th Report of expert Committee on Biological Standardization. Tech. Rep. Ser. Wld Hlth Org. no. 329.Google Scholar
W.H.O. (1966 b). Human viral and rickettsial vaccines. Report of a W.H.O. Scientific Group. Tech. Rep. Ser. Wld Hlth Org. no. 325.Google Scholar